已核实 DOI PubMed 相关产品: 19

Nitidine chloride induces cardiac hypertrophy in mice by targeting autophagy-related 4B cysteine peptidase

Journal 2022 · IF 7.169 · 44(3): 561-572 · 发表于 2022 年 8 月 19 日
作者: Hong Yang,Xu Wan-qing,Feng Jing,Lou Han,Liu Heng,Wang Lei,Cui Hao,Jiang Lin-tong,Xu Ran-chen,Xu Heng-hui,Xie Min-zhen,Li Yang,Kopylov Philipp,Wang Qi,Zhang Yong
阅读全文 在 PubMed 查看

摘要

Nitidine chloride (NC) is a standard active component from the traditional Chinese medicine Zanthoxylum nitidum (Roxb.) DC. (ZN). NC has shown a variety of pharmacological activities including anti-tumor activity. As a number of anti-tumor drugs cause cardiotoxicity, herein we investigated whether NC exerted a cardiotoxic effect and the underlying mechanism. Aqueous extract of ZN (ZNE) was intraperitoneally injected into rats, while NC was injected into beagles and mice once daily for 4 weeks. Cardiac function was assessed using echocardiography. We showed that both ZNE administered in rats and NC administered in mice induced dose-dependent cardiac hypertrophy and dysfunction, whereas administration of NC at the middle and high dose caused death in Beagles. Consistently, we observed a reduction of cardiac autophagy levels in NC-treated mice and neonatal mouse cardiomyocytes. Furthermore, we demonstrated that autophagy-related 4B cysteine peptidase (ATG4B) may be a potential target of NC, since overexpression of ATG4B reversed the cardiac hypertrophy and reduced autophagy levels observed in NC-treated mice. We conclude that NC induces cardiac hypertrophy via ATG4B-mediated downregulation of autophagy in mice. Thus, this study provides guidance for the safe clinical application of ZN and the use of NC as an anti-tumor drug.

本研究中使用的阿拉丁产品

19 款产品在本文中被引用